Vertebral bone marrow fat fraction changes in postmenopausal women with breast cancer receiving combined aromatase inhibitor and bisphosphonate therapy

被引：0
|
作者：
Michael Dieckmeyer
Stefan Ruschke
Alexander Rohrmeier
Jan Syväri
Ingo Einspieler
Vanadin Seifert-Klauss
Monika Schmidmayr
Stephan Metz
Jan S. Kirschke
Ernst J. Rummeny
Claus Zimmer
Dimitrios C. Karampinos
Thomas Baum
机构：
[1] Technische Universität München,Department of Diagnostic and Interventional Neuroadiology, Klinikum rechts der Isar
[2] Technische Universität München,Department of Radiology, Klinikum rechts der Isar
[3] University Medical Center Regensburg,Department of Radiology
[4] Technische Universität München,Department of Gynecology and Obstetrics, Klinikum rechts der Isar
来源：
BMC Musculoskeletal Disorders | / 20卷
关键词：
Osteoporosis; Bisphosphonates; Aromatase inhibitor; Vertebral bone marrow; Proton density fat fraction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women
    Kao, YC
    Okubo, T
    Sun, XZ
    Chen, S
    ANTICANCER RESEARCH, 1999, 19 (3A) : 2049 - 2056
  • [32] The effect of exercise training on endothelial function in postmenopausal women with breast cancer under aromatase inhibitor therapy
    Barbara, Mayr
    Bernhard, Reich
    Richard, Greil
    Josef, Niebauer
    CANCER MEDICINE, 2022, 11 (24): : 4946 - 4953
  • [33] Impact of chemotherapy on symptoms and symptom clusters in postmenopausal women with breast cancer prior to aromatase inhibitor therapy
    Li, Hongjin
    Sereika, Susan M.
    Marsland, Anna L.
    Conley, Yvette P.
    Bender, Catherine M.
    JOURNAL OF CLINICAL NURSING, 2019, 28 (23-24) : 4560 - 4571
  • [34] Prevalence of bisphosphonate therapy in women with breast cancer treated with aromatase inhibitors in Germany
    Jacob, Louis
    Kostev, Karel
    Hadji, Peyman
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (05) : 394 - 396
  • [35] Changes in regional brain metabolism following aromatase inhibitor therapy in postmenopausal women
    Silverman, Daniel
    Lee, Soo
    Geist, Cheri
    Yang, Chine Ching
    Togawa, Kayo
    Katheria, Vani
    Hansen, Kurt
    Patel, Sunita
    Czernin, Johannes
    Hurria, Arti
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [36] Aromatase Inhibitors and Mammographic Breast Density in Postmenopausal Women Receiving Estrogen Progestin Therapy
    Mousa, Noha A.
    Crystal, Pavel
    Wolfman, Wendy L.
    Bedaiwy, Mohamed A.
    Casper, Robert R.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (06): : 1219 - 1220
  • [37] Changes in bone mineral density (BMD) of postmenopausal women who are not receiving adjuvant endocrine therapy for breast cancer (BCA)
    Van Poznak, C.
    Morris, P. G.
    D'Andrea, G.
    Schott, A.
    Griggs, J.
    Fornier, M.
    Smerage, J.
    Henry, L.
    Collins, T.
    Hurria, A.
    Drullinsky, P.
    Mills, N. E.
    Hayes, D. F.
    Hudis, C.
    BONE, 2010, 47 : S308 - S308
  • [38] Adjuvant Aromatase Inhibitor Options in Overweight and Obese Postmenopausal Women with Breast Cancer
    Chlebowski, Rowan T.
    BREAST JOURNAL, 2013, 19 (05): : 552 - 554
  • [39] The effect of strength training combined with bisphosphonate (etidronate) therapy on bone mineral, lean tissue, and fat mass in postmenopausal women
    Chilibeck, PD
    Davison, KS
    Whiting, SJ
    Suzuki, Y
    Janzen, CL
    Peloso, P
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2002, 80 (10) : 941 - 950
  • [40] Association of adjuvant aromatase inhibitor with cataract risk in postmenopausal women with breast cancer
    Chen, Han
    Shao, Zhi-Ming
    Yu, Ke-Da
    Xu, Ge-Zhi
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
12345